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Human glomerular mesangial cells express CD16 and may be stimu-
lated via this receptor. CD16, a low affinity receptor for IgG, was found on
cultured human glomerular mesangial cells (GMC) by Western blot
analysis, cell ELISA and in situ hybridization. To characterize the mole-
cule in more detail, reverse polymerase chain reaction was performed and
the PCR products were analyzed. From sequence analysis and from
hybridization experiments with oligonucleotides specific for either the
transmembrane form or the glycosylphosphatidylinositol anchored form it
was found that GMC-CD16 was similar to NK-CD16. This indicates that
GMC express the transmembrane form of CD16. Comparison between
nonstimulated GMC and GMC stimulated by aggregated gammaglobulin
revealed no qualitative or quantitative difference in the expression of
CD16. Incubation of GMC with aggregated gammaglobulin or with
monoclonal antibodies to CD16 was followed by a time and dose
dependent release of interleukin-6, suggesting that signals were transmit-
ted by CD16. The occupancy of CD16 by immune complexes that may be
deposited in various forms of glomerulonephritis might contribute to the
perpetuation of inflammatory processes in the kidney.
Rat mesangial cells express a receptor for IgG that is homolo-
gous to the murine macrophage FcRIIa [1]. Via this receptor, an
immune complex mediated release of prostaglandins, superoxides
and platelet activation factor was observed [2, 3]. Sedmak, Singh
and Cosio [4] described the presence of the low affinity FcyRIII
receptor (CD16) on human glomerular mesangial cells (GMC) by
immunofluorescence techniques. CD16, a glycoprotein of 50 to 80
kDa, has been studied extensively on neutrophils (PMN) and
natural killer (NK) cells [reviewed in 5 and 6].
Two forms of CD16 exist which differ with regard to their
membrane anchor. Fc'yRIIIB is the glycosylphosphatidylinositol
(P1) linked protein found on PMN, whereas Fc'yRIIIA is an-
chored by a transmembrane domain and is expressed on NK cells,
macrophages and others [6—15]. Comparison of the CD16 eDNA
of NK cells and of PMN showed only minor differences [11—13],
which result in amino acid substitution at six positions. The most
intriguing differences are at amino acid positions 203 and 234. In
NK cell-CD16 phenylalanin is found in position 203 whereas in
PMN-CD16 it is serin. The latter determines the attachment of
the P1-anchor structure. Furthermore, a stop codon in PMN-
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CD16 is converted to CGA in NK-CD16, which codes for arginine
at position 234, thereby creating an open reading frame for 21
additional amino acids. These then form the cytoplasmatic do-
main of transmembrane CD16.
The present study investigated which of the two CD16 forms,
the transmembrane or the P1-anchored form, is expressed on
GMC. Furthermore, a possible functional role of CD16 on GMC
was evaluated by testing the ability of GMC to release cytokines
upon stimulation with aggregated gammaglobulin or with anti-
CD16 monoclonal antibodies, respectively.
Methods
Cells
Human glomerular mesangial cells were cultivated as described
previously [16, 17]. Cells of the fourth to seventh passages were
used. The cells were homogenous and showed the characteristic
morphology of mesangial cells. The cells were positive for myosin
and vimentin, and negative for CR1, Factor VIII and p44, a
staining pattern [18] that rules out contamination by monocytes,
endothelial and epithelial cells. Glomerular epithelial cells (GEC)
were also obtained from isolated glomeruli as described in [19].
Cells of the second passage were used. They were characterized by
their morphological appearance and being positive for p44 [18].
Polymorphonuclear neutrophils (PMN) were isolated by Polymor-
phprep (Nycomed, Oslo, Norway) using 3.5 to 5 ml of whole blood
treated with an anticoagulant.
Antibodies
Two anti-CD16 monoclonal antibodies were used for this study;
ION16 (hybridoma clone 3G8, murine IgGi) was purchased from
Dianova, 8H03 from Paesel. Mouse IgG for control purposes was
obtained from Dianova.
Quantitation of IL-6 released from GMC
GMC were seeded into 24-well culture plates at a density of
approximately 4 X iO cells per well. Varying amounts of aggre-
gated gammaglobulin (see below) or monoclonal antibodies to
CD16 (2 sg to 12 sg) were added in a total volume of 1 ml. After
6, 12 and 24 hours the supernatants were harvested and centri-
fuged. IL-6 was quantitated using a commercially available ELISA
(Biochrom, Berlin, Germany).
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Preparation of aggregated gammaglobulin
Three grams of purified human IgG (Sigma, MUnchen, Ger-
many) were resuspended in 300 ml of 0.15 M sodium chloride and
heated to 63°C for 15 minutes. Then 20 g of sodium sulphate was
added (1 hr at 4°C). After centrifugation (10 mm at 1500 g) the
pellet was resuspended in 10 ml distilled water. After dialysis
against veronal-buffered saline, the aggregated gammaglobulin
was harvested. The protein content was approximately 1 mg
protein/mi. Fifty microliters of the aggregated gammaglobulin
suspension was able to totally activate the complement system in
500 jd normal human serum. For stimulation of GMC, 5 to 20
jg/ml cell culture were used.
SDS-PAGE and Western blotting
A 4 to 17% gradient in a Laemmli system was used. Per lane
200 p.1 of a membrane protein extract in NP-40 was applied
containing 4 mg protein/mi. CD16 was detected using the mono-
cional anti-CD16 antibody 10N16 diluted to 20 p.g/ml, and
anti-mouse IgG peroxidase linked (Dianova, Hamburg, Germa-
ny). For control, mouse IgG was used in the same concentration.
Analysis of surface expression of CD1O by cell ELISA
A cell ELISA was performed using the method described in
[20] with minor modifications. In brief, the cells were cultivated in
96-well plates for 48 hours under various conditions and fixed with
0.05% glutaraldehyde in 0.1 M phosphate buffer for 15 minutes at
4°C. After washing with phosphate buffer, the cells were incubated
with 1% BSA for one hour at room temperature. Then anti-CD16
diluted in phosphate buffer containing 1% BSA was added in a
final concentration of 20 p.g/ml. After one hour at room temper-
ature and repeated washing in phosphate buffer containing 0.5%
Tween 20, peroxidase conjugated F(ab)2 goat anti-mouse IgG was
added. The substrate OPD (Dakopatts) was used. The reaction
was stopped with 2 N H2S04. Substrate conversion was monitored
as relative O.D. values at 450 nm. The mean SD of six
experiments was calculated. As control for nonspecific binding,
mouse IgG was used.
Sense and antisense cRNA preparation
Sense and antisense probes were prepared from CD16 eDNA
of nonstimulated GMC using the DIG RNA labeling kit, SP6/T7
(Boehringer, Mannheim, Germany), according to the protocol of
the manufacturer for cRNA preparation.
In situ hybridization
Cells that had been grown to subconfluency on chamber slides
(Nunc) were fixed with 4% paraformaldehyde solution in phos-
phate buffer, treated with 70% ethanol and stored at —80°C until
use, Prior to in situ hybridization cells were rehydrated with PBS,
acetylated by incubation for 10 minutes in 0.25% acetylanhydride,
0.1 M triethanolamine and 0.9% NaCl, and stepwise dehydrated by
ethanol. The slides were prehybridized for two hours at room
temperature in 20 to 30 1.d hybridization solution containing 4 X
SSC, 50% formamide, lx Denhardt's solution, 5% dextransul-
fate, 100 mrvi DTT, 0.25 mg/mI yeast tRNA and 0.5 mg/mi herings
sperm DNA. Hybridization was performed for 18 hours at 37°C
using 20 p.1 hybridization solution containing 10 ng/p.l Digoxyge-
nm (DIG) labeled antisense cRNA or 10 ng/p.l labeled sense
cRNA as negative control per slide. After hybridization the slides
were washed with 2 X SSC for 10 minutes, 1 X SSC for 20 minutes
at room temperature, 0.5 X SSC for 30 minutes at 37°C and 0.1 X
SSC for 10 minutes at room temperature. For detection the slides
were treated with mouse anti-DIG IgG (Boehringer) in 4 X SSC,
0.1% Tween 20 using 100 p.! per slide for one hour at 37°C. After
washing with 4 X SSC, 0.1% Tween 20 for 3 X 5 minutes at 37°C,
100 p.! rabbit anti-mouse IgG (3 p.g/ml) (Jackson Immunore-
search, West Grove, USA), in 4 x SSC, 0.1% Tween 20 was used
per slide. After incubation for 30 minutes at 37°C another washing
was performed as described above and 100 p.1 of goat anti-rabbit
IgG CY3 conjungated, 2.8 p.g/mi (Jackson Immunoresearch) were
added. After incubation for 30 minutes at 37°C the slides were
washed and treated with 20 p.! antifade containing 0.6% glycerin,
185 p.g/p.l Dabco (Diazabicyclo-[2.2.2]-Octane), 0.16 M NaHCO3,
and Dapi (4,6-Diamidino-2-phenylindole). For determination of
the percentage of positive cells, 120 cells were analyzed.
RNA extraction
Total RNA was extracted as described by Chomczynski and
Sacchi from 108 cultivated human GMC [21]. The cells were
washed twice with cold PBS, pelleted by centrifugation and lysed
by a solution containing 4 M guanidine isothiocyanate, 25 mM
sodiumcitrate, 5% sarcosylaureat, 0.1 M p-mercapto ethanol (so-
lution D). Five microliters of this solution was used per i07 cells.
The RNA was separated from the DNA by adding 0.1 vol
sodiumacetate, 1 vol phenol, and 0.3 vol chloroform/isoamylalco-
hol 49:1. After 15 minutes of incubation on ice and centrifugation
for 30 minutes at 10,000 rpm (Sorvall RC-5b-centrifuge, Rotor
Sorvall SM 24) at 4°C, the RNA in the hydrophilic phase was
collected and precipitated by 1 vol isopropanol and incubation for
two hours at —20°C. The pellet was resuspended in solution D,
and again precipitated with isopropanol. The RNA was dried
under vacuum and redissolved in DEPC-water.
Poly A -RWA selection
Poly A-RNA was extracted from total GMC RNA by the
DynabeadsR magnetic separation technique (DynabeadsR Oligo
dT, Dynal', A.S. Oslo, Norway). Two hundred microliters mag-
netic beads (5 mg/mi) per 75 p.g total RNA were used. The poly
A-RNA was eluted from the DynabeadsR with 5 p.l DEPC-
water.
Oligonucleotides
All oligonucleotides were synthesized on an Applied Biosys-
tems GMBH (Berlin) model 392. The oligonucleotide primers
and probes used in this study were derived from the published
cDNA sequence for CD16 [12] and are listed below.
Oligo 474: 1TFCTCCA1TFAAGTTTA (762-779) PMN specific
Oligo 489: ACAAACATTCGAAGOCA (724-741) NK specific
Oligo 490: ACAAACATITFGAAGCICA (724-741) PMN specific
Oligo 253: AGCTGGAAGAACACFGCfCFGCATA (221-445)
Oligo 252: GGGTCATTFGTCITGAGGGTCCTIT (777-801)
Oligo 255: CFGAGGAC VETCCACACAGTGGTT' (191-215)
Oligo 488: TFTCTCCA1TFAAA1TFA (762-779) NIK specific
Oligo 466/2: CATCACCAAGCAGAAAGAGACTFGG (654-678)
Oligo 256: AGATCI'CCCAAAGGCTGTGGTGlTC (97-121)
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Table 1. Quantification of CD16 on GMC by cell ELISA
Cell culture condition
CD16 expressiona
Anti-CD16 Mouse IgG
Culture medium
Culture medium + 40 U interferony,
Culture medium + 40 U interferony,
+ aggregated yglobulin (1 mg)
0.4 0.134
0.58 0.12
0.565 0.098
0.07 0.0898
0.078 0.024
0.085 0.056
a Values represent ELISA reading at 450 nm, mean SD (N = 6)
Reverse PCR
CD16 transcripts were amplified by reverse PCR (RNA-PCR-
Kit, Perkin Elmer Cetus). Briefly, 0.5 to 1 .tg poly A-RNA from
nonstimulated and stimulated GMC's was reverse transcribed for
one hour at 37°C using Moloney murine leukemia virus (M-MLV)
reverse transcriptase (Gibco/BRL) and Oligo dT. PCR was per-
formed with an aliquot of the obtained first-strand eDNA with
primers for CD16 (5'primer 256, 3'primer 252). The reaction was
carried out under the following conditions: denaturation one
minute at 94°C, annealing two minutes at 60°C, and extension
three minutes at 72°C, 30 cycles.
Southern blot analysis
The PCR products were electrophoresed (0.1 .tg/lane) in a 1%
agarose gel, and denatured in 1.5 M NaCI, 0.5 M NaOH. After
alkaline transfer to nylon membrane (Gene screen, Du Pont), the
DNA was cross linked by UV light (Stratalinker°° Stratagene,
Heidelberg, Germany). As positive control a PCR product de-
rived from a CD16-cDNA isolated from NK cells {12J was run on
the same gel. Prehybridization and hybridization were performed
in a solution containing 6 >< SSC, 0.01 M NaPO4 pH 6.8, 1 mM
EDTA pH 8, 0.5% SDS, 100 sg/ml herings sperm DNA. After the
addition of 0.5 pmol/ml 32P 5 end labeled oligonucleotides hybrid-
ization was carried out for six hours at a temperature 5°C under
the calculated melting temperature. The filter was exposed to
Kodak°, X-Omat X-ray film.
Subcloning and sequencing
The amplified DNA was purified from a 1% low melting point
agarose gel using the Gene Clean' kit (BlO 101 mc, La Jolla,
California, USA). The DNA was blunt end cloned into the Smal
site of BluescriptR SK phagemid vector (Stratagene) and trans-
formed into DH5a bacteria. After selection on ampicillin-Xgal-
isopropyl--thiogalactoside (IPTG) agar plates, the plasmid DNA
was extracted using the Magic°" Minipreps DNA Purification
System (Promega, USA). Three micrograms of double stranded
DNA were sequenced using the T7 Sequencing Kit (Pharmacia,
Milwaukee, Wisconsin, USA) and the following primers: Oligo
252, Oligo 253, Oligo 255, Oligo 256, Oligo 466/2, Oligo 489,
Oligo 474, T3 primer, T7 primer.
Results
Determination of CDI6 expression by cell ELISA
By cell ELISA with anti-CD16 monoclonal antibody 10N16
expression of CD16 was seen, whereas a mouse IgG control did
not show any reactivity (Table 1). Exposure of the GMC to
stimulating agents such as interferon -y, aggregated gammaglobu-
lin (Table 1), endotoxin and IL-i (data not shown) did not
increase the surface expression of CD16.
Fig. 1. Immunoblot of human GMC with monoclonal anti-CDI6 antibody
IONJO. Abbreviations are: MC mem, membrane fraction of GMC; MC
cyt, cytoplasmatic fraction.
Identification of CD16 by immunoblotting
GMC were harvested from the culture plate, and membrane
proteins were extracted by 1% NP-40. By Western blotting using
the anti-CD16 monoclonal antibody 10N16, a distinct band of
about 66,000 Da could be detected in the membrane fraction as
well as in the cytoplasma (Fig. 1). Glomerular epithelial cells used
as control showed no reaction (data not shown). Non-immune
mouse IgG did not react with the cell fractions tested (data not
shown).
In situ hybridization
To test for the presence of CD16-mRNA, in situ hybridization
of cultured GMC was performed using a triple layer immunode-
tection with fluorescent labeling. With a CD16 cRNA antisense
probe strong signals were seen in approximately 85% of the
subconfluently grown GMC. At high power magnification there
were densely packed intracytoplasmatic granular signals (Fig. 2a).
Signal intensity and density showed only slight variations. The
intensity of background signals was low to moderate. With a CD16
sense probe the low signal intensity of the GMC cytoplasm did not
exceed the background level (Fig. 2b). Glomerular epithelial cells
did not show any reactivity with the antisense probe (data not
shown).
Analysis of the CD16 anchor
Reverse PCR was performed on poly A-RNA of nonstimu-
lated GMC and GMC stimulated by aggregated gammaglobulin.
97.4 —
66.2 —
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FIg. 2. In situ hybridization. (a) In situ hybridization of cultured GMC with a CD1fi specific antisense cRNA ()< 1000): two cells with densely packed
intracytoplasmatic granular signals are shown. (b) A CD16 specific sense cRNA was used as control: three cells with low intracytoplasmatic signal
intensity not exceeding the background level are presented (x 1000).
Using the CD16 specific primers 256 and 252, a 0.8 kb band was types as well as with oligonucleotides specific for either the
detected by agarose gel electrophoresis. The PCR products were transmembrane or the P1 linked form of CD16. A strong hybrid-
hybridized with an oligonucleotide common to both receptor ization signal was seen with the common internal oligonucleotide
Fig. 3. Southern blot analysis. Hybridization of
CD16 PCR products with oligonucleotides
specific for either the transmembrane form
(NK) or the P1-linked form of CD16 (PMN) or
with an oligonucleotide specific for both forms
(common). Lane 1: NK cell CD16 cDNA; lane
2: nonstimulated GMC; lane 3: stimulated
GMC; lane 4: polymorphonuclear neutrophils
(PMN).
253. The reactivity of the PCR product from nonstimulated cells
was similar to that obtained from stimulated GMC. The same
result was obtained with the NK specific oligonucleotides 489,
488. No reactivity with the neutrophil specific oligonucleotides
474, 490 was seen with the CD16-specific PCR products of GMC
(Fig. 3). These data indicate, that GMC might express the
transmembrane form of CD16.
Sequence analysis
To confirm the Southern blot data we subcloned the amplified
cDNA (5'primer 256, 3'primer 252) obtained from nonstimulated
GMC and GMC stimulated by aggregated gammaglobulin as well
as from different PCR products. Ten clones were analyzed by the
dideoxy chain termination method. The sequence was nearly
identical to the published sequences for CD16 on NK cells [12]
encoding a transmembrane protein. The only difference in nude-
otide sequence compared to the published data was at position
559, where a G instead of T was found (Fig. 4).
Stimulation of GMC via the receptor for CD16
To test whether GMC might be stimulated by aggregated
gammaglobulin, cultivated GMC were incubated with increasing
amounts of aggregated IgG for 6, 12 and 24 hour. As parameter
for activation, release of interleukin-6 (IL-6) into the cell super-
natant was measured. Depending on the dose of the aggregated
IgG, an increase in IL-6 release was seen already after six hours
that increased with time (Fig. 5 a and b). In a next series of
experiments monoclonal antibodies to CD16 were tested. Two
different monoclonal antibodies (derived from different clones)
with presumeably different epitope specificities were used. Both
antibodies caused a dose and time-dependent increase of IL-6
(Fig. 6 a and b); the monoclonal antibody 8H03 was slightly less
efficient when compared to 10N16. The increased IL-6 release
could not be observed using the same concentrations of mouse
IgG.
Discussion
Recently, a low affinity Fc receptor has been described in rat
glomerular mesangial cells [1—3] and later also in human GMC
[4]. By Western Blot analysis, cell ELISA and in situ hybridization,
we could confirm the presence of the low affinity Fc receptor for
IgG, CD16 (FcyRIII), on human GMC. So far, two different
genes A and B have been described that are expressed in different
cell types. FcyRIIIA is the transmembrane form of the protein
that is expressed on NK cells. Presumably it mediates antibody-
dependent cellular cytotoxicity (ADCC), generation of superox-
ides and interleukin-6 synthesis [6, 14, 22, 23]. The FcyRIIIB gene
codes for a protein that is anchored to the membrane via a
P1-anchor and is expressed on neutrophils. Again it is thought to
be involved in the initiation of ADCC and, in addition, in the
release of lysosomal enzymes [6, 14, 22, 23]. To analyze which
form of CD16 is expressed on GMC, PCR products obtained from
poly A-RNA of GMC were hybridized with oligonucleotides
specific for either the PT-linked or the transmembrane form. A
signal was seen only with the oligonucleotide specific for the
transmembrane form of NK cell-CD 16. These data were con-
firmed by sequence analysis of CD16 PCR products. With one
exception, the sequence of the analyzed clones was identical to the
published sequence for NK cells. A difference, however, was
found at position 559 where G was identified instead of a T. This
nucleotide substitution determines an exchange of the amino acid
phenylalanine to valin. Whether this reflects a GMC-specific
1 2
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HEU
HR TTTGGTGACTTGTCCACTCCAGTCTGGCATC ATG TGG CAC CTG CTC CTC
MET TRP GLH LEIJ LEt) LEt)
NEt)
HR CCA ACT GOT CTG CTA CTT CTA GTT TCA CCT CCC ATG CCG ACT
52 PRO T1 ALA LEt) LEG LEG LW VAL SER ALA CLI MET ARG TMR
NEt)
GMC/HK GAA CAT CTC CCA AAg GCT GTG CTG TTC CTG GAG CCT CAA TCC
94 GLU ASP LEU PRO LIS ALA VAL VAL PHE LEG GLU PRO GLH TRP
SER
HEU C T
GMC/HK TAC AGG GTG CTC GAG AAG GAC ACT GTG ACT CTG AAC TGC CAC
136 TIR ARC VAL LEU GLU LIS ASP SER VAL THR LEG LIS CIS GLH
HEU
GMC/NK CGA CCC TAC TCC CCT GAG GAC ART TCC ACA CAG TCG TTT CAC
178 CLI ALA TIR SER PRO CLU ASP ASH SER THR GLH TRP PHE HIS
NEt)
CMC/HK AAT GAG AGC CTC ATC TCA ACC CAG CCC TCG AGC TAC TTC ATT
220 ASH GLU SER LEU ILE SER SER GLH ALA SER SER TIR PME ILE
ASH
HEU A
GMC/HE GAC CCT CCC ACA GTC GAC GAC ACT GGA GAG TAC ACG TGC GAG
262 ASP ALA ALA TMR VAL ASP ASP SER CLI GLU TIR ARF CIS GLH
NEU
GMC/HR ACA AAC CTC TCC ACC CTC ACT GAC CCC GTG CAG CTA GAA GTC
304 TMR ASH LEU SER TMR LEU SER ASP PRO VAL CLH LEG CLU VAL
HEU
GMC/HK CAT ATC GGC TGG CTC TTG CTC CAG CCC CCT CCG TGG GTG TTC
346 MIS ILE CLI TRP LEG LEU LEG GLN ALA PRO ARG TRP VAL PHE
HEU
GMC/HR AAC GAG GAA GAC CCT ATT CAC CTG AGC TCT CAC AGC TGG AAG
388 LIS GLU GLU ASP PRO ILE HIS LEU ARC CIS HIS SER TRP LIS
HEU
GMC/H1< ARC ACT GCT CTG CAT ARC GTC ACA TAT TTA CAG ART CCC AAA
430 ASH TMR ALA LEt) HIS LIS VAL TMR TIR LEt) GLH ASH CLI LIS
ASP MIS
HEU .A C
GMC/HK GGC AGG ARC TAT TTT CAT CAT ART TCT GAC TTC TAC ATT CCA
472 CLI ARC LIS TIR PME MIS HIS ASH SER ASP PME TYR ILE PRO
HEU T
GMC/HK AAR GCC ACA CTC AAA GAC ACC GGC TCC TAC TTC TGC AGG GGG
514 LIS ALA TMR LEU CTC ASP SER GLI SER TIR PME CIS ARC CLI
VAL
HEU . .. .G
CMC . . . .G
HR CTT TTT GCG ACT AAA ART GTG TCT TCA GAG ACT GTC ARC ATC
556 LEG PHE CLI SER LIS ASH VAL SER SER CLU TMR VAL ASH ILE
HEU
CMC/HK ACC ATC ACT CAR CGT TTC GCA CTC TCA ACC ATC TCA TCA TTC
598 TMR ILE TMR GLH CLI LEU ALA VAL SER THR ILE SER SER PHE
SER
HEU .C
GMC/HK TTT CCA CCT GGG TAC CAR GTC TCT TTC TGC TTG GTG ATG CTA
640 PHE PRO PRO CLI TIR GLH VAL SER PHE CIS LEt) VAL MET VAL
HEU
GMC/HK CTC CTT TTT CCA CTG GAC ACA CGA CTA TAT TTC TCT CTG ARC Fig. 4. Sequence analysis of the CDJÔ transcript
682 LEU LEU PME ALA VAL ASP THR CLI LEU TIR PME SER VAL LIS of GMC and predicted amino acid sequence.
Comparison with the transcripts of neutrophils
GMC/NK ACAAACATTCGAAGCTCAACAAGACACTGGAAGGACCATAAR (NEU) and NKcells (NK? described in [12].
724 THR ASH ILE ARC SER SER TMR ARG ASP TRP LIS ASP HIS LIS Numbers indicate nucleotide positions.Sequencing of the GMC-CD16 PCR products
HEU C started from position 97. The 21 additional
GHC/HR TTT AAA TCG AGA ARC GAC CCT CAR GAC AAA TGA CCC 801 amino acids of the cytoplasmatie domain of
766 PME LIS TRP ARC NK-CD16 are underlined.
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Fig. 5A. Release of IL -6 from GMC following stimulation with aggregated IgG. (A) Various amounts of aggregated IgG were added and release into the
supernatant was measured after 24 hour. (B) Two doses of aggregated IgG were added and release into the supernatant was measured after various
times (hr). The values represent the means of three parallel experiments. Symbols are: (U) 20 .tg/ml; (D) 10 .sgfml.
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Fig. 6. Release of IL-6 from GMC following stimulation by antibodies to CD16. (A) Various amounts of anti-CD16 (10N16) were added and release
of IL-6 was measured after 24 hours. Mouse IgG was used for comparison. (B) The effect of two different clones with specificity for CD16 was tested.
Antibodies or control IgG were added in concentrations of 20 /Lg/ml and release into the supernatant was measured after various times (hr). Symbols
in A are: (0) anti-CD16; (+) mouse IgG. Symbols in B are: (+) ION 16; (0) 8 1103; (*) mouse IgG.
0 6 12 24
1634 Morcos et al: CD16 on human glomerular mesangial cells
replacement or whether it is due to the individual donor cannot be
decided as yet. When PCR products obtained from nonstimulated
GMC were compared to those obtained from immune complex
stimulated cells, no difference was revealed by sequencing analy-
sis. We conclude that only one Fc receptor type, transmembrane
CD16, is expressed on human GMC.
To assess the function of this Fc receptor on GMC, the effect of
aggregated gammaglobulin was tested. As parameter for GMC
activation, release of IL-6 was measured. Depending on the dose
of aggregated IgG release of IL-6 was seen. A similar effect was
observed with two different monoclonal antibodies to CD16. Our
data are in line with studies of rat mesangial cells, where also a Fc
receptor with remarkable homology to the murine FcyRIIa was
found [1—3]. Similarly to our observations, immune complexes
trigger rat mesangial cells via the Fc receptor; release of super-
oxides, eicosanoids and platelet activating factor were seen [2, 3].
The physiological function of Fcy receptors in the mesangium is
not yet known. Expression of CD16 could not be demonstrated in
cryostate section of normal kidney, neither by antibodies to CD16
[4] nor by in situ hybridization (unpublished observation). Only on
cultivated GMC, CD16 was apparent. Since cultivated cells to
some degree represent a more "activated cell type" as opposed to
a quiescent tissue cell, one might speculate that CD16 expression
in the mesangium occurs only after mesangial cell activation, may
be during inflammation. Evidence for a participation of CD16 in
inflammatory processes is only indirect: in various forms of
glomerulonephritis IL-6 could be demonstrated in areas of im-
mune complex deposits and of mesangial proliferation [24, 25].
Considering the fact, that immune complexes trigger IL-6 release,
our data support the notion that immune complexes via CD16
participate indirectly in mesangium expansion.
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